Literature DB >> 26802624

Venomous snakebites in children in southern Croatia.

Svjetlana Karabuva1, Ivana Vrkić2, Ivica Brizić3, Ivo Ivić4, Boris Lukšić5.   

Abstract

This retrospective study represents observation of 160 children and adolescents aged up to 18 years that experienced venomous snakebites in southern Croatia and were treated in the Clinical Department of Infectious Diseases in the University Hospital Centre Split from 1979 to 2013. The main purpose of this research was to determine the epidemiological characteristics, clinical presentation, local and general complications, and received treatment. Most bites occurred during warm months, from early May to late August (80%), mostly in May and June. Upper limb bites were more frequent (59%) than lower limb bites (40%). Out of the total number of poisoned children, 24% developed local, and 25% general complications. The most common local complications were haemorrhagic blisters that occurred in 20% children, followed by compartment syndrome presented in 7.5% patients. The most dominated general complication was cranial nerve paresis or paralysis, which was identified in 11.2% patients, whereas shock symptoms were registrated in 7% children. According to severity of poisoning, 9.4% children had minor, 35% mild, 30.6% moderate, and 24.4% had severe clinical manifestation of envenomation. Only one (0.6%) child passed away because of snakebite directly on the neck. All patients received antivenom produced by the Institute of Immunology in Zagreb, tetanus prophylaxis as well, and almost all of them received antibiotics, and a great majority of them also received corticosteroids and antihistamines. Neighter anaphylactic reaction nor serum disease were noticed in our patients after administrating antivenom. A total of 26% children underwent surgical interventions, and incision of haemorrhagic blister was the most common applied surgical treatment, which was preformed in 15.6% patients, while fasciotomy was done in 7.5% subjects. All of our surgically treated patients recovered successfully.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antivenom; Children; Compartment syndrome; Croatia; Snakebite; Viper venom

Mesh:

Substances:

Year:  2016        PMID: 26802624     DOI: 10.1016/j.toxicon.2016.01.057

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  12 in total

1.  Management and Prognosis of Snake Envenomation Among Pediatric Patients: A National Database Study.

Authors:  Lin-Chi Chiang; Chung-Hsien Chaou; Yi-Yun Li; Chen-June Seak; Shiuan-Ruey Yu; Chih-Chuan Lin
Journal:  J Acute Med       Date:  2022-03-01

2.  Genomic Confirmation of the P-IIIe Subclass of Snake Venom Metalloproteinases and Characterisation of Its First Member, a Disintegrin-Like/Cysteine-Rich Protein.

Authors:  Kity Požek; Adrijana Leonardi; Jože Pungerčar; Weiqiao Rao; Zijian Gao; Siqi Liu; Andreas Hougaard Laustsen; Alenka Trampuš Bakija; Katarina Reberšek; Helena Podgornik; Igor Križaj
Journal:  Toxins (Basel)       Date:  2022-03-23       Impact factor: 5.075

3.  Antivenom Production against Bothrops jararaca and Bothrops erythromelas Snake Venoms Using Cross-Linked Chitosan Nanoparticles as an Immunoadjuvant.

Authors:  Karla Samara Rocha Soares; Fiamma Gláucia-Silva; Alessandra Daniele-Silva; Manoela Torres-Rêgo; Nathália Kelly de Araújo; Yamara Arruda Silva de Menezes; Igor Zumba Damasceno; Denise Vilarinho Tambourgi; Arnóbio Antônio da Silva-Júnior; Matheus de Freitas Fernandes-Pedrosa
Journal:  Toxins (Basel)       Date:  2018-04-16       Impact factor: 4.546

4.  Evaluating temporal patterns of snakebite in Sri Lanka: the potential for higher snakebite burdens with climate change.

Authors:  Dileepa Senajith Ediriweera; Peter John Diggle; Anuradhani Kasturiratne; Arunasalam Pathmeswaran; Nipul Kithsiri Gunawardena; Shaluka Francis Jayamanne; Geoffrey Kennedy Isbister; Andrew Dawson; David Griffith Lalloo; Hithanadura Janaka de Silva
Journal:  Int J Epidemiol       Date:  2018-12-01       Impact factor: 7.196

5.  Variability in venom composition of European viper subspecies limits the cross-effectiveness of antivenoms.

Authors:  Giulia Zanetti; Elisa Duregotti; Carlo Alessandro Locatelli; Andrea Giampreti; Davide Lonati; Ornella Rossetto; Marco Pirazzini
Journal:  Sci Rep       Date:  2018-06-29       Impact factor: 4.379

6.  Preclinical Assessment of a New Polyvalent Antivenom (Inoserp Europe) against Several Species of the Subfamily Viperinae.

Authors:  Alejandro García-Arredondo; Michel Martínez; Arlene Calderón; Asunción Saldívar; Raúl Soria
Journal:  Toxins (Basel)       Date:  2019-03-05       Impact factor: 4.546

7.  Comprehensive Study of the Proteome and Transcriptome of the Venom of the Most Venomous European Viper: Discovery of a New Subclass of Ancestral Snake Venom Metalloproteinase Precursor-Derived Proteins.

Authors:  Adrijana Leonardi; Tamara Sajevic; Jože Pungerčar; Igor Križaj
Journal:  J Proteome Res       Date:  2019-04-24       Impact factor: 4.466

8.  Intravenous Vipera berus Venom-Specific Fab Fragments and Intramuscular Vipera ammodytes Venom-Specific F(ab')2 Fragments in Vipera ammodytes-Envenomed Patients.

Authors:  Tihana Kurtović; Svjetlana Karabuva; Damjan Grenc; Mojca Dobaja Borak; Igor Križaj; Boris Lukšić; Beata Halassy; Miran Brvar
Journal:  Toxins (Basel)       Date:  2021-04-14       Impact factor: 4.546

9.  Evaluating spatiotemporal dynamics of snakebite in Sri Lanka: Monthly incidence mapping from a national representative survey sample.

Authors:  Dileepa Senajith Ediriweera; Anuradhani Kasthuriratne; Arunasalam Pathmeswaran; Nipul Kithsiri Gunawardene; Shaluka Francis Jayamanne; Kris Murray; Takuya Iwamura; Geoffrey Isbister; Andrew Dawson; David Griffith Lalloo; Hithanadura Janaka de Silva; Peter John Diggle
Journal:  PLoS Negl Trop Dis       Date:  2021-06-01

10.  Thrombocytopenic purpura following envenomation by the nose-horned viper (Vipera ammodytes ammodytes): Two case reports.

Authors:  Boris Lukšić; Svjetlana Karabuva; Joško Markić; Branka Polić; Tanja Kovačević; Julije Meštrović; Igor Križaj
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.